• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . The hinge-engineered IgG1-IgG3 hybrid subclass IgGh47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antib

tetano

Editor, Senior Moderator
Nat Commun


. 2024 Apr 27;15(1):3600.
doi: 10.1038/s41467-024-47928-8. The hinge-engineered IgG1-IgG3 hybrid subclass IgGh[SUB]47[/SUB] potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies

Arman Izadi[SUP] 1 [/SUP], Yasaman Karami[SUP] 2 3 [/SUP], Eleni Bratanis[SUP] 1 [/SUP], Sebastian Wrighton[SUP] 1 [/SUP], Hamed Khakzad[SUP] 2 [/SUP], Maria Nyblom[SUP] 4 [/SUP], Berit Olofsson[SUP] 1 [/SUP], Lotta Happonen[SUP] 1 [/SUP], Di Tang[SUP] 1 [/SUP], Martin Sundwall[SUP] 1 [/SUP], Magdalena Godzwon[SUP] 5 [/SUP], Yashuan Chao[SUP] 1 [/SUP], Alejandro Gomez Toledo[SUP] 1 [/SUP], Tobias Schmidt[SUP] 6 [/SUP], Mats Ohlin[SUP] 5 [/SUP], Michael Nilges[SUP] 3 [/SUP], Johan Malmström[SUP] 1 [/SUP], Wael Bahnan[SUP] 1 [/SUP], Oonagh Shannon[SUP] 1 7 [/SUP], Lars Malmström[SUP] 1 [/SUP], Pontus Nordenfelt[SUP] 8 9 [/SUP]



Affiliations
Abstract

Streptococcus pyogenes can cause invasive disease with high mortality despite adequate antibiotic treatments. To address this unmet need, we have previously generated an opsonic IgG1 monoclonal antibody, Ab25, targeting the bacterial M protein. Here, we engineer the IgG2-4 subclasses of Ab25. Despite having reduced binding, the IgG3 version promotes stronger phagocytosis of bacteria. Using atomic simulations, we show that IgG3's Fc tail has extensive movement in 3D space due to its extended hinge region, possibly facilitating interactions with immune cells. We replaced the hinge of IgG1 with four different IgG3-hinge segment subclasses, IgGh[SUB]xx[/SUB]. Hinge-engineering does not diminish binding as with IgG3 but enhances opsonic function, where a 47 amino acid hinge is comparable to IgG3 in function. IgGh[SUB]47[/SUB] shows improved protection against S. pyogenes in a systemic infection mouse model, suggesting that IgGh[SUB]47[/SUB] has promise as a preclinical therapeutic candidate. Importantly, the enhanced opsonic function of IgGh[SUB]47[/SUB] is generalizable to diverse S. pyogenes strains from clinical isolates. We generated IgGh[SUB]47[/SUB] versions of anti-SARS-CoV-2 mAbs to broaden the biological applicability, and these also exhibit strongly enhanced opsonic function compared to the IgG1 subclass. The improved function of the IgGh[SUB]47[/SUB] subclass in two distant biological systems provides new insights into antibody function.


 
Back
Top Bottom